365 - FAMILY FEUD

Saturday, October 26, 2024

4:30 PM – 5:30 PM PT

Room: 212-213

Join us for an exciting Family Feud-style session at the Canadian Cardiovascular Congress. Contestants from the East take on their counterparts from the West! Be ready to cheer for your region!

This engaging event promises fun, learning, and friendly rivalry—who will emerge victorious in the ultimate East vs. West showdown?

Don't miss your chance to be part of the action!

Disclosure(s):

Gurmeet Singh, MD: Abbott Medical: Honoraria (Ongoing)

Dave Nagpal, MD, FRCSC: No financial relationships to disclose

Sonia S. Anand, MD, PhD, FRCPC: Bayer AG: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Daiichi Sankyo: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen Pharmaceuticals: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); novartis: speaker (Ongoing); Novonordisk: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Subodh Verma, MD PhD FRCSC FAHA FCCS FCAHS: Amarin: Speaker/Honoraria (Ongoing); Amgen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Astrazeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Canadian Medical and Surgical Knowledge Translation Research Group: Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Humber River Health: Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Merck: Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); PhaseBio: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); S & L Solutions Event Management Inc: Speaker/Honoraria (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Sun Pharma: Speaker/Honoraria (Ongoing)

Saurabh Gupta, MD, MSc: Edwards Lifesciences: Speaker/Honoraria (Ongoing)

Luc Mertens, MD: No financial relationships to disclose

Robert JH Miller, MD, FRCPC: Pfizer: Amyloidosis research (Ongoing), Consulting (modest, <5k) (Ongoing)

Justin Cloutier, MD, FRCPC: No financial relationships to disclose

Jasmine Grewal, MD, FRCPC: No financial relationships to disclose

Margot K. Davis, MD, MSc, FRCPC: Abbott: Speaking honoraria (Ongoing); Alnylam: advisory board honoraria (Ongoing); Anthos: Ad board honoraria (Ongoing); AstraZeneca: Ad board honoraria (Ongoing), Research steering committee, research funding (Ongoing); BI-Lilly: Ad board honoraria (Ongoing); Ferring: Ad board honoraria (Ongoing), Speaking honoraria (Ongoing); Janssen: Ad board honoraria (Ongoing), Consulting and speaking honoraria (Ongoing), Research funding (Ongoing); Jazz Pharmaceuticals: Ad board honoraria (Ongoing); Novo Nordisk: Advisory board honoraria (Ongoing), Consulting fees (Ongoing); Pfizer: consulting honoraria (Ongoing), research funding (Ongoing), speaking and consulting honoraria (Ongoing)

Kim A. Connelly, MBBS, PhD, FSCMR, FCCS: Abbott: Consultant (Ongoing), Speaker (Ongoing); AstraZeneca: Consultant (Ongoing), Principal investigator Co-Investigator on human studies and preclinical research (Ongoing), Speaker (Ongoing); Boehringer Ingelheim: Consultant (Ongoing), Inventor of Medical use of a DPP4 inhibitor (Ongoing), Principal investigator Co-Investigator on human studies and preclinical research (Ongoing), Speaker (Ongoing); Eli Lilly: Consultant (Ongoing), Speaker (Ongoing); GSK: Consultant (Ongoing), Speaker (Ongoing); Janssen: Consultant (Ongoing), Speaker (Ongoing); MDBriefcase: Speaker/Honoraria (Ongoing); Medscape: Speaker/Honoraria (Ongoing); Merck: Consultant (Ongoing), Principal investigator Co-Investigator on human studies and preclinical research (Ongoing), Speaker (Ongoing); Northern Therapeutics Inc.: Advisory Board Member (Ongoing); Novo Nordisk: Consultant (Ongoing), Principal investigator Co-Investigator on human studies and preclinical research (Ongoing), Speaker (Ongoing); Sanofi: Consultant (Ongoing), Speaker (Ongoing); Servier: Principal investigator Co-Investigator on human studies and preclinical research (Ongoing), Speaker (Ongoing)

Chi-Ming Chow, MD MSc FRCPC FCCS: Khure Health: Consultant/Advisory Board (Ongoing); Podcast AI: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Usqaure Soft Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Chair(s)

GS

Gurmeet Singh, MD

CARDIAC SURGEON
CCS, CANCARE, CSCS
CANCARE, CSCS

Team East(s)

DN

Dave Nagpal, MD, FRCSC

Cardiac Surgery / Critical Care Medicine
CCS, CSCS, CANCARE, CCTN
Western University
Sonia S. Anand, MD, PhD, FRCPC (she/her/hers)

Professor of Medicine; President of CSVM
McMaster University
McMaster University
Subodh Verma, MD PhD FRCSC FAHA FCCS FCAHS (he/him/his)

Cardiac Surgeon
St. Michael's Hospital
University of Toronto
Saurabh Gupta, MD, MSc (he/him/his)

Cardiovascular Surgeon
New Brunswick Heart Centre
Dalhousie University New Brunswick
Luc Mertens, MD

Section Head, Echocardiography
CCS,CPCA
University of Toronto

Team West(s)

Robert JH Miller, MD, FRCPC (he/him/his)

Clinical Associate Professor
Libin Cardiovascular Institute of Alberta
University of Calgary, Libin Cardiovascular Institute
Sheri Koshman, BScPharm, PharmD, ACPR, FCSHP

Associate Professor
University of Alberta
University of Alberta
JC

Justin Cloutier, MD, FRCPC (he/him/his)

Cardiologist
Canadian society of echocardiography
University of Manitoba
Jasmine Grewal, MD, FRCPC

Clinical Professor, University of British Columbia
CACH-Net
University of British Columbia
Margot K. Davis, MD, MSc, FRCPC (she/her/hers)

Clinical Assistant Professor, University of British Columbia
University of British Columbia
University of British Columbia

Judge(s)

Kim A. Connelly, MBBS, PhD, FSCMR, FCCS (he/him/his)

Executive Director, Keenan Research Centre & Division Head of Cardiology
St. Michael's Hospital, Unity Health Toronto
University of Toronto
Chi-Ming Chow, MD MSc FRCPC FCCS

Director of Echo Lab
St. Michael's Hospital
University of Toronto